BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/10/2023 8:49:38 AM | Browse: 191 | Download: 526
 |
Received |
|
2022-09-24 14:58 |
 |
Peer-Review Started |
|
2022-09-24 15:00 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-11-15 14:35 |
 |
Revised |
|
2022-12-06 08:17 |
 |
Second Decision |
|
2022-12-27 03:19 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2022-12-28 03:49 |
 |
Articles in Press |
|
2022-12-28 03:49 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-01-03 06:19 |
 |
Publish the Manuscript Online |
|
2023-01-10 08:49 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng and Ying-Tang Gao |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Natural Science Foundation of Tianjin Science and Technology Bureau |
No. 21JCZDJC01050 |
Tianjin Key Medical Discipline (Specialty) Construction Project |
No. TJYXZDXK-034A |
Tianjin Municipal Health Science and Technology Project |
No. TJWJ2021ZD003, KJ20068, KJ20129, TJWJ2022XK029 |
|
Corresponding Author |
Ying-Tang Gao, PhD, Professor, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Nankai University Affiliated Third Center Hospital, No. 83 Jintang Road, Hedong District
, Tianjin 300170, China. gaoyt816@163.com |
Key Words |
Recurrent hepatocellular carcinoma; Local regional therapy; Systemic therapy; Tumor microenvironment; Recurrence type; Immune checkpoint inhibitors |
Core Tip |
Hepatocellular carcinoma (HCC) is a highly recurrent malignancy; at present, there is a lack of definite treatment strategies for recurrent HCC. Recurrent HCC has particularities in recurrence mode and tumor microenvironment, so its treatment strategy should be different from that of primary HCC. Systemic therapy based on the immune microenvironment has emerged as a potential alternative treatment option for advanced HCC. Combining local therapy and systemic therapy for recurrent HCC may achieve better effects and is worthy of further exploration. |
Publish Date |
2023-01-10 08:49 |
Citation |
Liang J, Bai Y, Ha FS, Luo Y, Deng HT, Gao YT. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World J Gastrointest Oncol 2023; 15(1): 1-18 |
URL |
https://www.wjgnet.com/1948-5204/full/v15/i1/1.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v15.i1.1 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345